Share on LinkedInShare on LinkedIn

ARTICLE · 02 JULY 2026

AlixPartners' Response To The EC's Consultation On Draft New Merger Guidelines

The European Commission has released its first major update to Merger Guidelines since 2008, introducing significant changes to how mergers are assessed. AlixPartners experts Paul Armstrong, Federica Grilli, Julie Bon, and Ben Forbes have submitted a detailed consultation response examining key areas including counterfactual analysis, innovation shields, efficiency treatment, and the need for greater clarity on remedies and symmetry in harm assessment.

United KingdomAntitrust/Competition Law

The European Commission (EC) has published draft new Merger Guidelines – its first major update since 2008. Paul Armstrong, Federica Grilli, Julie Bon, and Ben Forbes have responded to the consultation. View our full response below or download a copy.

Key points from our submission:

The counterfactual could go further. The Guidelines now address failing firms and refer to the "exit of firms" from a market, but they also exclude changes "under the control of a party to the merger." A firm exiting for strategic reasons sits between the two. It would help if the Commission clarified whether a counterfactual in which a target exits, or becomes a weaker competitor, can be considered.

The innovation shield is a welcome addition – with one question. The shield gives certainty to deals that leave at least three independent innovators. However, it may exclude sectors where R&D capability is already concentrated for reasons unrelated to the merger. These are also the sectors where the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from